Behavioral Neuroscience – News and Features

News
MCG Participating in National Study to Identify Genetic Variants in Schizophrenia
Study will examine the genes of 10,000 patients with schizophrenia and 10,000 healthy individuals in an effort to improve disease diagnosis and treatment.

News
NeuroScience Pharmaceuticals Launches in Research Triangle Park
Company develops treatments for brain disorders, utilizing technology licensed from Duke University and Durham Veterans Affairs Medical Center.

News
Rutgers University Cell and DNA Repository Adopts Cryostor™ as Standard Biopreservation Media
Decision based on improved recovery and elimination of serum in cryopreservation of cell lines used in worldwide disease research efforts.

News
Exercise is Safe, Improves Quality of Life in Patients with Chronic Heart Failure
Regular exercise is safe for heart failure patients and may slightly lower their risk of death or hospitalization, NHLBI study finds.

News
Young Adults at Future Risk of Alzheimer's Have Different Brain Activity, Says Study
A genetic variant raising the risk of developing Alzheimer's in young adults show changes in their brain activity decades before any symptoms might arise.

News
UT Southwestern Researchers Reveal How the Brain Processes Important Information
Researchers shed light on how the neurotransmitter dopamine helps certain brain cells to become more flexible and changes brain-cell circuitry.

News
Study Suggests Listening to Pleasant Music Could Help Restore Vision in Stroke Patients
Patients who have lost part of their visual awareness following a stroke can show an improved ability to see when they are listening to music they like, according to a new study published in the journal Proceedings of the National Academy of Sciences.

News
Researchers Develop DNA "Patch" for Canine form of Muscular Dystrophy
This finding lays the foundation for human testing.

News
Evotec and Roche to Develop EVT 101 for Treatment-Resistant Depression
Under the agreement, Evotec will conduct Phase II studies for EVT 101, a compound originally discovered by Roche.

News
Schizophrenia Linked to Signaling Problems in New Brain Study
The study supports the theory that abnormalities in the way in which cells 'talk' to each other are involved in the disease.
Advertisement